Home The Word Brain	My Amedeo FAQ Privacy About	Flying Publisher
	The Angels Initiative Stroke prevention

Dermatology

Free Subscription 16.01.2023 6 BMC Cancer 9 Br J Dermatol 3 Cancer 1 Cancer Lett 4 Clin Exp Dermatol 8 Cutis 4 Int J Dermatol 2 J Cutan Pathol 3 J Dermatol 5 J Invest Dermatol 6 Lancet 1 Mycoses 1 N Engl J Med 1 Nat Rev Cancer 4 PLoS One

Retrieve available abstracts of this week’s articles: HTML format

Single Articles

BMC Cancer

1. ZHANG C, Liang Z, Liu W, Zeng X, et al
   Comparison of whole-body 18F-FDG PET/CT and PET/MRI for distant metastases in patients with malignant tumors: a meta-analysis.
   BMC Cancer. 2023;23:37.
   PubMed         Abstract available
   
   
2. VERBEEK JGE, de Jong VMT, Wijnja HM, Jager A, et al
   High-dose chemotherapy with stem cell rescue to treat stage III homologous deficient breast cancer: factors influencing clinical implementation.
   BMC Cancer. 2023;23:26.
   PubMed         Abstract available
   
   
3. WANG AJ, McCann B, Soon WCL, De Ieso PB, et al
   Merkel cell carcinoma: a forty-year experience at the Peter MacCallum Cancer Centre.
   BMC Cancer. 2023;23:30.
   PubMed         Abstract available
   
   
4. DENG H, Wang L, Wang N, Zhang K, et al
   Neoadjuvant checkpoint blockade in combination with Chemotherapy in patients with tripe-negative breast cancer: exploratory analysis of real-world, multicenter data.
   BMC Cancer. 2023;23:29.
   PubMed         Abstract available
   
   
5. HUANG S, Yang Q, Zheng X, Chow KM, et al
   Predictors of surgery choices in women with early-stage breast cancer in China: a retrospective study.
   BMC Cancer. 2023;23:23.
   PubMed         Abstract available
   
   
6. LIU S, Du S, Gao S, Teng Y, et al
   A delta-radiomic lymph node model using dynamic contrast enhanced MRI for the early prediction of axillary response after neoadjuvant chemotherapy in breast cancer patients.
   BMC Cancer. 2023;23:15.
   PubMed         Abstract available
   
   

   
   Br J Dermatol

7. HE X, Shi H
   How does acral melanoma respond to immunotherapy?
   Br J Dermatol. 2022 Nov 10:ljac035. doi: 10.1093.
   PubMed        
   
   
8. YOTSU RR, Fuller LC, Murdoch ME, Revankar C, et al
   World Health Organization strategic framework for integrated control and management of skin-related neglected tropical diseases: what does this mean for dermatologists?
   Br J Dermatol. 2022 Oct 20:ljac031. doi: 10.1093.
   PubMed        
   
   
9. WITTLICH M, Westerhausen S, Strehl B, Versteeg H, et al
   The GENESIS-UV study on ultraviolet radiation exposure levels in 250 occupations to foster epidemiological and legislative efforts to combat nonmelanoma skin cancer.
   Br J Dermatol. 2022 Nov 11:ljac093. doi: 10.1093.
   PubMed         Abstract available
   
   
10. MIDANDER K, Werner P, Isaksson M, Wisgrill L, et al
    Cobalt nanoparticles cause allergic contact dermatitis in humans.
    Br J Dermatol. 2022 Oct 28:ljac043. doi: 10.1093.
    PubMed         Abstract available
    
    
11. ROSENO NAL, Lorup EH, Richardson C, Alarcon I, et al
    Exploring disease comorbidities and temporal disease progression of psoriasis: an observational, retrospective, multi-database, cohort study.
    Br J Dermatol. 2022 Nov 11:ljac086. doi: 10.1093.
    PubMed         Abstract available
    
    
12. BRAVO FG
    Assessing the use of biologic therapy for psoriasis in Latin America.
    Br J Dermatol. 2023 Jan 13:ljad003. doi: 10.1093.
    PubMed        
    
    
13. YUE W, Cheng D, Sun Z, Shen Y, et al
    Validation of diagnostic criteria for atopic dermatitis and proposal of novel diagnostic criteria for adult and elderly Chinese populations: a multicentre, prospective, clinical setting-based study.
    Br J Dermatol. 2022 Dec 12:ljac097. doi: 10.1093.
    PubMed         Abstract available
    
    
14. HU C, Jansen PW
    Do adolescents with atopic dermatitis have lower cognitive function and school performance than their peers without atopic dermatitis?
    Br J Dermatol. 2022 Nov 29:ljac105. doi: 10.1093.
    PubMed        
    
    
15. CLAYTON K, Holbrook DJ, Vallejo A, Porter G, et al
    Skin programming of inflammatory responses to Staphylococcus aureus is compartmentalized according to epidermal keratinocyte differentiation status.
    Br J Dermatol. 2022 Nov 17:ljac088. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cancer

16. 
    Collagen type XII linked with poor overall survival in breast cancer.
    Cancer. 2023;129:331-332.
    PubMed        
    
    
17. GU J, Tong T, Xu D, Cheng F, et al
    Deep learning radiomics of ultrasonography for comprehensively predicting tumor and axillary lymph node status after neoadjuvant chemotherapy in breast cancer patients: A multicenter study.
    Cancer. 2022 Nov 19. doi: 10.1002/cncr.34540.
    PubMed         Abstract available
    
    
18. AUGUSTIN RC, Luke JJ
    Top advances of the year: Melanoma.
    Cancer. 2023 Jan 11. doi: 10.1002/cncr.34590.
    PubMed        
    
    

    
    Cancer Lett

19. GANDULLO-SANCHEZ L, Pandiella A
    An anti-EGFR antibody-drug conjugate overcomes resistance to HER2-targeted drugs.
    Cancer Lett. 2023;554:216024.
    PubMed         Abstract available
    
    

    
    Clin Exp Dermatol

20. FEITO-RODRIGUEZ M, Ramirez-Bosca A, Vidal-Asensi S, Fernandez-Nieto D, et al
    Randomised double blind placebo controlled clinical trial to evaluate the effect of a mixture of probiotic strains on symptom severity and the use of corticosteroids in children and adolescents with atopic dermatitis.
    Clin Exp Dermatol. 2023 Jan 13:llad007. doi: 10.1093.
    PubMed         Abstract available
    
    
21. LIM YT, Robinson S, Tang MM
    Liver Disease Among Patients with Psoriasis: The Malaysian Psoriasis Registry.
    Clin Exp Dermatol. 2023 Jan 12:llad013. doi: 10.1093.
    PubMed         Abstract available
    
    
22. RUGGIERO A, Megna M, Caiazzo G, Parisi M, et al
    Author reply to: Comment on: 'Eczematous drug eruption in patients with psoriasis under anti-interleukin-17A: does interleukin-22 play a key role?'.
    Clin Exp Dermatol. 2022 Dec 22:llac130. doi: 10.1093.
    PubMed        
    
    
23. KANJI A, Hussain K, Patel NP
    Opportunities for implementing a patient-initiated follow-up pathway for patients with psoriasis completing phototherapy.
    Clin Exp Dermatol. 2022 Dec 7:llac114. doi: 10.1093.
    PubMed         Abstract available
    
    

    
    Cutis

24. DANESHBOD Y, Ahmed I, Kerstetter J
    Psoriasiform Dermatitis Associated With the Moderna COVID-19 Messenger RNA Vaccine.
    Cutis. 2022;110:E1-E4.
    PubMed        
    
    
25. MATTHEWS S, Young C, Litzner B
    Yellow Papules and Plaques on a Child.
    Cutis. 2022;110:262-269.
    PubMed        
    
    
26. HUNT MJ, Elston DM
    Botanical Briefs: Toxicodendron Dermatitis.
    Cutis. 2022;110:270-273.
    PubMed         Abstract available
    
    
27. HAFT MA, Sui JY, Choi M, Eichenfield LF, et al
    Past, Present, and Future of Pediatric Atopic Dermatitis Management.
    Cutis. 2022;110:259-261.
    PubMed        
    
    
28. LYON PR, Burgess B, Berg EA, Fernandez MP, et al
    Cutaneous and Subcutaneous Perineuriomas in 2 Pediatric Patients.
    Cutis. 2022;110:277-280.
    PubMed         Abstract available
    
    
29. COKER HB 4TH, Mountcastle EA
    Primary Malignant Melanoma of the Middle Ear.
    Cutis. 2022;110:E12-E14.
    PubMed        
    
    
30. LIO PA
    Dietary Triggers for Atopic Dermatitis in Children.
    Cutis. 2022;110:264-266.
    PubMed        
    
    
31. GUENTHER J, Johnson H, Yu J, Adler BL, et al
    Photoallergic Contact Dermatitis: No Fun in the Sun.
    Cutis. 2022;110:241-267.
    PubMed         Abstract available
    
    

    
    Int J Dermatol

32. ALMUHANA G, Alsalhi A, Alsalhi H, Al-Hoqail IA, et al
    New insight into the management of toxic epidermal necrolysis following the coadministration of lamotrigine and valproic acid.
    Int J Dermatol. 2023 Jan 13. doi: 10.1111/ijd.16584.
    PubMed        
    
    
33. PETTIT C, Trinidad J, Chung C, Patterson A, et al
    Hospital triage and skin disease: hospital outcomes are differentially associated with cutaneous morphology.
    Int J Dermatol. 2023 Jan 13. doi: 10.1111/ijd.16575.
    PubMed         Abstract available
    
    
34. YAMAMOTO T, Miura K, Eishi Y
    Detection of Propionibacterium acnes in cutaneous lichenoid sarcoidosis in a patient with Blau syndrome.
    Int J Dermatol. 2023 Jan 12. doi: 10.1111/ijd.16583.
    PubMed        
    
    
35. MODESTI CA, Alves JP, Leopoldo LR, Bonamigo RR, et al
    Segmental stiff skin syndrome: report of a rare disease.
    Int J Dermatol. 2023 Jan 11. doi: 10.1111/ijd.16577.
    PubMed        
    
    

    
    J Cutan Pathol

36. ROCCUZZO G, Avallone G, Cavallo F, Mastorino L, et al
    Synchronous occurrence of primary cutaneous B-cell lymphoma and cutaneous Rosai Dorfman disease in distinct lesions: a unique association.
    J Cutan Pathol. 2023 Jan 13. doi: 10.1111/cup.14391.
    PubMed         Abstract available
    
    
37. KOZERA EK, Langan R, Singh-Grewal D, Sun HY, et al
    Neonatal lupus erythematosus presenting as a non-bullous histiocytoid neutrophilic dermatosis.
    J Cutan Pathol. 2023 Jan 8. doi: 10.1111/cup.14387.
    PubMed         Abstract available
    
    

    
    J Dermatol

38. NAKASHIMA C, Kato M, Otsuka A
    Cutaneous manifestations of COVID-19 and COVID-19 vaccination.
    J Dermatol. 2023 Jan 13. doi: 10.1111/1346-8138.16651.
    PubMed         Abstract available
    
    
39. FUJITA Y, Sugai T, Maya Y, Inamura E, et al
    Secukinumab-induced oral lichen planus in a psoriatic arthritis patient ameliorated after a switch to risankizumab.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16719.
    PubMed         Abstract available
    
    
40. TADA Y, Itakura A, Hosono K, Kawamura T, et al
    Psoriasis patient preferences for the use of biologics during the coronavirus era.
    J Dermatol. 2023 Jan 11. doi: 10.1111/1346-8138.16703.
    PubMed         Abstract available
    
    

    
    J Invest Dermatol

41. LIU W, Xu R, Wang F
    Recent Advances of Basophils in Pruritic Skin Diseases.
    J Invest Dermatol. 2023 Jan 4:S0022-202X(22)02889.
    PubMed         Abstract available
    
    
42. GROLLEAU C, Calugareanu A, Demouche S, Nosbaum A, et al
    IL-4/IL-13 inhibitors for atopic dermatitis induce psoriatic rash transcriptionally close to pustular psoriasis.
    J Invest Dermatol. 2023 Jan 4:S0022-202X(22)02817.
    PubMed         Abstract available
    
    
43. MENG Q, Bai M, Guo M, Li Z, et al
    Inhibition of serum and glucocorticoid-regulated protein kinase-1 aggravates imiquimod-induced psoriatic dermatitis and enhances proinflammatory cytokine expression via the NF-kappaB pathway.
    J Invest Dermatol. 2023 Jan 6:S0022-202X(23)00007.
    PubMed         Abstract available
    
    
44. KANG T, Zhang C, Lei H, Luo R, et al
    NPTX2 Promotes EMT in Cutaneous Squamous Cell Carcinoma via Mettl3-Mediated m(6)A Methylation of Snail.
    J Invest Dermatol. 2023 Jan 10:S0022-202X(23)00009.
    PubMed         Abstract available
    
    
45. AGARWAL A, Orlow SJ
    Skin in the Game: An Analysis of Venture Capital Investment in Dermatology from 2002 to 2021.
    J Invest Dermatol. 2023 Jan 11:S0022-202X(22)02767.
    PubMed        
    
    

    
    Lancet

46. CHUA BH, Link EK, Kunkler IH, Olivotto IA, et al
    Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost? - Authors' reply.
    Lancet. 2023;401:24.
    PubMed        
    
    
47. MULLIEZ T, De Ridder M
    Breast radiotherapy for non-low-risk ductal carcinoma in situ: to boost or not to boost?
    Lancet. 2023;401:23-24.
    PubMed        
    
    
48. MEROLA JF, Landewe R, McInnes IB, Mease PJ, et al
    Bimekizumab in patients with active psoriatic arthritis and previous inadequate response or intolerance to tumour necrosis factor-alpha inhibitors: a randomised, double-blind, placebo-controlled, phase 3 trial (BE COMPLETE).
    Lancet. 2023;401:38-48.
    PubMed         Abstract available
    
    
49. QUEIRO R
    Bimekizumab in psoriatic arthritis: a great leap forward?
    Lancet. 2023;401:2-3.
    PubMed        
    
    
50. MCINNES IB, Asahina A, Coates LC, Landewe R, et al
    Bimekizumab in patients with psoriatic arthritis, naive to biologic treatment: a randomised, double-blind, placebo-controlled, phase 3 trial (BE OPTIMAL).
    Lancet. 2023;401:25-37.
    PubMed         Abstract available
    
    
51. MITJA O, Ogoina D, Titanji BK, Galvan C, et al
    Monkeypox.
    Lancet. 2023;401:60-74.
    PubMed         Abstract available
    
    

    
    Mycoses

52. GALILI E, Goldsmith T, Khanimov I, Arbel C, et al
    Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response.
    Mycoses. 2023;66:144-149.
    PubMed         Abstract available
    
    

    
    N Engl J Med

53. TANG B, Chang X
    Condylomata Lata.
    N Engl J Med. 2023;388:e3.
    PubMed        
    
    

    
    Nat Rev Cancer

54. SENFT D
    Leptin fuels non-genetic skin tumour progression.
    Nat Rev Cancer. 2023 Jan 11. doi: 10.1038/s41568-023-00548.
    PubMed        
    
    

    
    PLoS One

55. DAMMU H, Ren T, Duong TQ
    Deep learning prediction of pathological complete response, residual cancer burden, and progression-free survival in breast cancer patients.
    PLoS One. 2023;18:e0280148.
    PubMed         Abstract available
    
    
56. JI X, Chen H, Xie L, Chen S, et al
    The study of GSDMB in pathogenesis of psoriasis vulgaris.
    PLoS One. 2023;18:e0279908.
    PubMed         Abstract available
    
    
57. WIJESOORIYA H, Samaranayake N, Karunaweera ND
    Cytokine and phenotypic cell profiles in human cutaneous leishmaniasis caused by Leishmania donovani.
    PLoS One. 2023;18:e0270722.
    PubMed         Abstract available
    
    
58. YUAN Y, Liu X, Cai Y, Li W, et al
    Pyrotinib versus lapatinib therapy for HER2 positive metastatic breast cancer patients after first-line treatment failure: A meta-analysis and systematic review.
    PLoS One. 2023;18:e0279775.
    PubMed         Abstract available
    
    

Thank you for your interest in scientific medicine.

AMEDEO Dermatology is free of charge. This policy is made possible thanks to a media sponsorship by Boehringer Ingelheim. Design: